Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Dan Zou, Rui Zhang, Lei Yu, Tingting Hu & Bin Wu. (2023) Seizures associated with antibiotics: a real-world disproportionality analysis of FAERS database. Expert Opinion on Drug Safety 22:11, pages 1143-1148.
Read now
Read now
Weixuan Zhao & Hongmei Meng. (2022) Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population. Bioengineered 13:3, pages 7709-7745.
Read now
Read now
Pony Yee-Chee Chai, Chian-Ting Chang, Yi-Hua Chen, Hui-Yu Chen & Ka-Wai Tam. (2021) Effect of drug interactions between carbapenems and valproate on serum valproate concentration: a systematic review and meta-analysis. Expert Opinion on Drug Safety 20:2, pages 215-223.
Read now
Read now
Toni A Campanella & Jason C Gallagher. (2020) A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date. Infection and Drug Resistance 13, pages 4297-4308.
Read now
Read now
Owen R. Albin, Twisha S. Patel & Keith S. Kaye. (2018) Meropenem–vaborbactam for adults with complicated urinary tract and other invasive infections. Expert Review of Anti-infective Therapy 16:12, pages 865-876.
Read now
Read now
Zhi Peng Wen, Shuang Shi Fan, Can Du, Tao Yin, Bo Ting Zhou, Ze Feng Peng, Yuan Yang Xie, Wei Zhang, Yao Chen, Jie Tang, Jian Xiao & Xiao Ping Chen. (2016) Influence of Acylpeptide Hydrolase Polymorphisms on Valproic Acid Level in Chinese Epilepsy Patients. Pharmacogenomics 17:11, pages 1219-1225.
Read now
Read now
Eiko Suzuki, Daisuke Nakai, Hidenori Ikenaga, Keiichi Fusegawa, Ryoya Goda, Nobuhiro Kobayashi, Hiroshi Kuga & Takashi Izumi. (2016) In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs. Xenobiotica 46:2, pages 126-131.
Read now
Read now
Yuya Sato, Mayuko Okuya, Susumu Hagisawa, Takashi Matsushita, Keitaro Fukushima, Hidemitsu Kurosawa, Kenichi Sugita & Osamu Arisaka. (2011) Viridans Streptococcal Bacteremia–Related Encephalopathy in Childhood with Malignancy. Pediatric Hematology and Oncology 28:1, pages 24-30.
Read now
Read now
Articles from other publishers (67)
Nick Petrucelli, Bryan D Hayes, Nidhi Shelat, Ramy H Elshaboury, Jeffrey C Pearson & Jennifer L Koehl. (2024) Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective Analysis. Open Forum Infectious Diseases 11:3.
Crossref
Crossref
Samantha Elledge, Kyle Klindworth, Jennifer Guy, Lindsey DeZotell & Ashley K. Holmes. (2022) Evaluating the Effects of Ertapenem and Meropenem on Tacrolimus. Journal of Pharmacy Practice 36:6, pages 1419-1423.
Crossref
Crossref
Xin Y. Chu & Paul C.L. Ho. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
483
500
.
Andrew J. Fratoni, Jessica L. Colmerauer, Kristin E. Linder, David P. Nicolau & Joseph L. Kuti. (2021) A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working?. Journal of Pharmacy Practice 36:3, pages 537-541.
Crossref
Crossref
Xuping Yang, Zhenwei Jiang, Yan Jiang, Jing Ling, Lulu Dong, Sulan Zou, Rong Chen & Nan Hu. (2023) Determination of valproic acid and its six metabolites in human serum using LC–MS/MS and application to interaction with carbapenems in epileptic patients. Biomedical Chromatography 37:3.
Crossref
Crossref
Kyle A. Weant & Haili Gregory. (2023) Optimizing Status Epilepticus Management in the Emergency Department. Advanced Emergency Nursing Journal 45:1, pages 11-22.
Crossref
Crossref
Patrick J. Coppler & Jonathan Elmer. (2023) Status Epilepticus. Critical Care Clinics 39:1, pages 87-102.
Crossref
Crossref
Anna J. Kiss-Szemán, Luca Takács, Zoltán Orgován, Pál Stráner, Imre Jákli, Gitta Schlosser, Simonas Masiulis, Veronika Harmat, Dóra K. Menyhárd & András Perczel. (2022) A carbapenem antibiotic inhibiting a mammalian serine protease: structure of the acylaminoacyl peptidase–meropenem complex. Chemical Science 13:48, pages 14264-14276.
Crossref
Crossref
Elise J. Smolders, Rob Ter Heine, Stephanie Natsch & Kees Kramers. (2022) Meropenem to Treat Valproic Acid Intoxication. Therapeutic Drug Monitoring 44:3, pages 359-362.
Crossref
Crossref
Stephanie Seto, Amanda Rivera & Megan E. Barra. 2022. The Acute Neurology Survival Guide. The Acute Neurology Survival Guide
339
342
.
Kazuya Maeda, Akihiro Hisaka, Kiyomi Ito, Yoshiyuki Ohno, Akihiro Ishiguro, Reiko Sato & Naomi Nagai. (2021) Classification of drugs for evaluating drug interaction in drug development and clinical management. Drug Metabolism and Pharmacokinetics 41, pages 100414.
Crossref
Crossref
Sachin M. Patil & Parag Patel. 2021. Infections and Sepsis Development. Infections and Sepsis Development.
Salia Farrokh, Christina Roels, Kent A. Owusu, Sarah E. Nelson & Aaron M. Cook. (2020) Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges. Neurocritical Care 34:2, pages 593-607.
Crossref
Crossref
Manuel Ibarra, Iñaki F. Trocóniz & Pietro Fagiolino. (2021) Enteric reabsorption processes and their impact on drug pharmacokinetics. Scientific Reports 11:1.
Crossref
Crossref
Igor N. SychevL.V. FedinaDmitriy A. Sychev. (2021) Antibiotic therapy under polypragmatic conditions: a course to safety. Clinical Microbiology and Antimicrobial Chemotherapy 23:4, pages 367-373.
Crossref
Crossref
I-Ling Chen, Chen-Hsiang Lee, Shu-Chen Hsiao & Fu-Yuan Shih. (2020) Interactions between carbapenems and valproic acid among the patients in the intensive care units. Journal of Critical Care.
Crossref
Crossref
Laurent M. Willems, Sebastian Bauer, Kolja Jahnke, Martin Voss, Felix Rosenow & Adam Strzelczyk. (2020) Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review. CNS Drugs 34:8, pages 801-826.
Crossref
Crossref
Jinxin Shi, Chengpeng Sun, Huilian Huang, Wenhui Lin, Jian Gao, Yanhe Lin, Zhanjun Zhang, Xiaokui Huo, Xiangge Tian, Zhenlong Yu, Baojing Zhang & Xiaochi Ma. (2020)
β
‐Glucuronidase‐ and
OATP2B1
‐mediated drug interaction of scutellarin in Dengzhan Xixin Injection: A formulation aspect
. Drug Development Research 81:5, pages 609-619.
Crossref
Crossref
Daniel Muñoz-Pichuante, Lorenzo Villa-Zapata & Russi Lolas. (2020) Meropenem for management of valproic acid overdose: a case report. Drug Metabolism and Drug Interactions 35:2.
Crossref
Crossref
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, Miho Kazui, Hidetaka Sakurai & Daisuke Nakai. (2020) Identification of non-P450 enzymes involved in the metabolism of new drugs: Their significance in drug interaction evaluation and prodrug disposition. Drug Metabolism and Pharmacokinetics 35:1, pages 45-55.
Crossref
Crossref
Izhar Ullah, Essa Ali & Fakhar-ud-Din. 2020. Antibiotics and Antimicrobial Resistance Genes. Antibiotics and Antimicrobial Resistance Genes
211
238
.
Le Zou, Fanqi Meng, Weici Wang, Qianqian Ye, Lin Hu, Taoming Li & Tao Yin. (2019) A novel analytical method to assess the effect of imipenem/cilastatin on liver function laboratory indexes in Chinese underage inpatients: Probability distribution curve. PLOS ONE 14:10, pages e0224352.
Crossref
Crossref
Juan Chen, Qibiao Su, Jiaming Qin, Yi Zhou, Honglian Ruan, Ziyi Chen, Zhuojia Chen, Hongliang Li, Yafang Zhou, Shan Zhou, Xueding Wang, Liemin Zhou & Min Huang. (2019) Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy. Drug Metabolism and Pharmacokinetics 34:3, pages 165-171.
Crossref
Crossref
M. A. Khobrani, S. W. Dudley, Y. C. Huckleberry, B. J. Kopp, A. D. Biggs, R. N. E. French, F. M. Shirazi & B. L. Erstad. (2018) Intentional use of carbapenem antibiotics for valproic acid toxicity: A case report. Journal of Clinical Pharmacy and Therapeutics 43:5, pages 723-725.
Crossref
Crossref
Martin Holtkamp & William H. Theodore. (2018) Generic antiepileptic drugs—Safe or harmful in patients with epilepsy?. Epilepsia 59:7, pages 1273-1281.
Crossref
Crossref
Larry H. Danziger & Karolyn S. Horn. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
1
56
.
Samuel Deshayes, Antoine Coquerel & Renaud Verdon. (2017) Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. Drug Safety 40:12, pages 1171-1198.
Crossref
Crossref
Z.-P. Wen, S.-S. Fan, C. Du, T. Yin, B.-T. Zhou, Z.-F. Peng, Y.-Y. Xie, W. Zhang, Y. Chen, J. Xiao & X.-P. Chen. (2017) Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients. Journal of Clinical Pharmacy and Therapeutics 42:2, pages 221-227.
Crossref
Crossref
Chi‐Ren Huang, Chih‐Hsiang Lin, Shu‐Chen Hsiao, Nai‐Ching Chen, Wan‐Chen Tsai, Shang‐Der Chen, Yan‐Ting Lu & Yao‐Chung Chuang. (2017) Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. The Kaohsiung Journal of Medical Sciences 33:3, pages 130-136.
Crossref
Crossref
Peter Bede, Diane Lawlor, Damodar Solanki & Norman Delanty. (2016) Carbapenems and valproate: A consumptive relationship. Epilepsia Open 2:1, pages 107-111.
Crossref
Crossref
Upendarrao Golla, Deepthi Joseph & Raghuvir Singh Tomar. (2016) Combined Transcriptomics and Chemical-Genetics Reveal Molecular Mode of Action of Valproic acid, an Anticancer Molecule using Budding Yeast Model. Scientific Reports 6:1.
Crossref
Crossref
Elena S?nchez-Y??ez, Clara Esta?n-Mart?nez & Guillermo Ojeda Burgos. (2016) Meropenem y ?cido valproico: interacci?n farmacol?gica cl?nicamente relevante. Enfermedades Infecciosas y Microbiolog?a Cl?nica 34:8, pages 536-537.
Crossref
Crossref
A. Suarez-de-la-Rica, C. Hern?ndez-Gancedo, A. L?pez-Tofi?o, E. Maseda & F. Gilsanz. (2016) Severe cefepime-induced status epilepticus treated with haemofiltration. Revista Espa?ola de Anestesiolog?a y Reanimaci?n 63:6, pages 353-356.
Crossref
Crossref
Michael Paulzen, Chin-Bin Eap, Gerhard Gründer & Maxim Kuzin. (2016) Pharmacokinetic Interaction Between Valproic Acid, Meropenem, and Risperidone. Journal of Clinical Psychopharmacology 36:1, pages 90-92.
Crossref
Crossref
Trevor Hill, Carol Coupland, Richard Morriss, Antony Arthur, Michael Moore & Julia Hippisley-Cox. (2015) Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64?years: cohort study using a primary care database. BMC Psychiatry 15:1.
Crossref
Crossref
Anthony G. Marson & Graeme J. Sills. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy
652
666
.
Edoardo Spina & Domenico Italiano. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy
344
359
.
Mª Concepción Miranda Herrero, Andrés J. Alcaraz Romero, Vicente Escudero Vilaplana, Sarah Nicole Fernández Lafever, Cecilia Martínez Fernández-Llamazares, Estibaliz Barredo Valderrama, María Vázquez López & Pedro de Castro. (2015) Pharmacological interaction between valproic acid and carbapenem: What about levels in pediatrics?. European Journal of Paediatric Neurology 19:2, pages 155-161.
Crossref
Crossref
Yohei Doi & Henry F. Chambers. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
293
297.e2
.
Rebecca Johnson, Richard Lancaster & Timothy Ku. 2015. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care
525
547
.
Elizabeth Duggan & Nabil M. Elkassabany. 2015. A Case Approach to Perioperative Drug-Drug Interactions. A Case Approach to Perioperative Drug-Drug Interactions
527
530
.
Gaetano Zaccara & Emilio Perucca. (2015) Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disorders 16:4, pages 409-431.
Crossref
Crossref
Anu Marahatta, Bidur Bhandary, Seul-Ki Jeong, Hyung-Ryong Kim & Han-Jung Chae. (2014) Soybean greatly reduces valproic acid plasma concentrations: A food–drug interaction study. Scientific Reports 4:1.
Crossref
Crossref
M. V?lez-D?az-Pallar?s, N. Vicente-Oliveros, E. Delgado-Silveira, C. P?rez-Men?ndez-Conde, A. ?lvarez-D?az & T. Bermejo-Vicedo. (2014) Impacto de las alertas interactivas modales en la prescripci?n informatizada de ?cido valproico y meropenem. Revista de Calidad Asistencial 29:1, pages 17-21.
Crossref
Crossref
Firas A. Taha, David N. Hammond & Raj D. Sheth. (2013) Seizures From Valproate–Carbapenem Interaction. Pediatric Neurology 49:4, pages 279-281.
Crossref
Crossref
Hyonok Yoon & Diana H. Kim. (2013) Unusual drug reaction between valproate sodium and meropenem. International Journal of Clinical Pharmacy 35:3, pages 316-318.
Crossref
Crossref
Min Kyu Park, Kyoung Soo Lim, Tae-Eun Kim, Hye-Kyung Han, So-Jeong Yi, Kwang-Hee Shin, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2012) Reduced Valproic Acid Serum Concentrations Due to Drug Interactions With Carbapenem Antibiotics. Therapeutic Drug Monitoring 34:5, pages 599-603.
Crossref
Crossref
KENJI TAKEUCHI, MASAKAZU SHIBATA, EIJI KASHIYAMA & KEN UMEHARA. (2012) Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats. Experimental and Therapeutic Medicine 4:3, pages 524-532.
Crossref
Crossref
Alberto Alemán & Lucas Martín Romano. (2012) Ácido valproico y meropenem; una mala asociación. Descripción de dos casos y revisión de la literatura. Neurología Argentina 4:3, pages 126-131.
Crossref
Crossref
M. V?lez-D?az-Pallar?s, E. Delgado Silveira, A.M. ?lvarez D?az, C. P?rez Men?ndez-Conde, N. Vicente Oliveros & T. Bermejo Vicedo. (2012) Analysis of the valproic acid-meropenem interaction in hospitalised patients. Neurolog?a (English Edition) 27:1, pages 34-38.
Crossref
Crossref
M. V?lez D?az-Pallar?s, E. Delgado Silveira, A.M. ?lvarez D?az, C. P?rez Men?ndez-Conde, N. Vicente Oliveros & T. Bermejo Vicedo. (2012) An?lisis de la interacci?n ?cido valproico-meropenem en pacientes hospitalizados. Neurolog?a 27:1, pages 34-38.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
419
460
.
Mar?a Isabel Fern?ndez Garc?a, Rafael ?ngel Fern?ndez de la Puebla Gim?nez, Beatriz Garc?a Olid & Virginia Torres Degay?n. (2011) Meropenem disminuye los niveles plasm?ticos de valproato. Medicina Cl?nica 137:1, pages 43-44.
Crossref
Crossref
April D. Miller, Amanda M. Ball, P. Brandon Bookstaver, Emily K. Dornblaser & Charles L. Bennett. (2012) Epileptogenic Potential of Carbapenem Agents: Mechanism of Action, Seizure Rates, and Clinical Considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:4, pages 408-423.
Crossref
Crossref
Masashi Ishihara, Kiyoyuki Kitaichi, Katsuhiko Matsuura, Hiroshi Nakamura, Hisashi Tsurumi, Hisataka Moriwaki & Yoshinori Itoh. (2011) Rikkunshi-to Partially Reverses Cancer Chemotherapy-Induced Decrease in Plasma Valproic Acid Concentration in a Patient with Malignant Lymphoma. Chinese Medicine 02:02, pages 58-61.
Crossref
Crossref
Ursula Theuretzbacher & Markus Zeitlinger. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
443
454
.
Elias B. Chahine, Mary J. Ferrill & Mara N. Poulakos. (2010) Doripenem: A new carbapenem antibiotic. American Journal of Health-System Pharmacy 67:23, pages 2015-2024.
Crossref
Crossref
Michael PfallerAnton Peleg & Margaret Salmon. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition
500
513
.
Eiko Suzuki, Naotoshi Yamamura, Yuji Ogura, Daisuke Nakai, Kazuishi Kubota, Nobuhiro Kobayashi, Shin-ichi Miura & Osamu Okazaki. (2010) Identification of Valproic Acid Glucuronide Hydrolase As a Key Enzyme for the Interaction of Valproic Acid with Carbapenem Antibiotics. Drug Metabolism and Disposition 38:9, pages 1538-1544.
Crossref
Crossref
Gail Anderson. 2010. Epilepsy. Epilepsy
229
253
.
Danièle Bentué-Ferrer, Olivier Tribut & Marie-Clémence Verdier. (2010) Suivi thérapeutique pharmacologique du valproate. Therapies 65:3, pages 233-240.
Crossref
Crossref
Kristine Willett, Kirthana RamanJessica Nichols & Cheryl Durand. (2010) Doripenem: The Newest Addition to Carbapenem Antibiotics. Journal of Pharmacy Technology 26:1, pages 14-21.
Crossref
Crossref
HENRY F. CHAMBERS. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
341
345
.
Ram Mani & John R. Pollard. (2009) Antiepileptic drugs and other medications: What interactions may arise?. Current Treatment Options in Neurology 11:4, pages 253-261.
Crossref
Crossref
V. San Antonio Arce & B. Joyanes Abancens. (2009) Meropenem y ácido valproico: una interacción a recordar. Anales de Pediatría 70:2, pages 193-194.
Crossref
Crossref
Takaharu Mizutani. (2009) Toxicity of Xanthene Food Dyes by Inhibition of Human Drug-Metabolizing Enzymes in a Noncompetitive Manner. Journal of Environmental and Public Health 2009, pages 1-9.
Crossref
Crossref
S.James Matthews & Jason W. Lancaster. (2009) Doripenem monohydrate, a broad-spectrum carbapenem antibiotic. Clinical Therapeutics 31:1, pages 42-63.
Crossref
Crossref